Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic disorders. These naturally occurring molecules are secreted by the gut in response to nutrient intake, https://getsocialnetwork.com/story5998450/unveiling-the-therapeutic-potential-of-glp-1-peptides